Showing results (71-80 of 84) with videos related to
Sort By:
Pageof 9
Journal of Molecular Medicine (Berlin, Germany)|April 28, 2020
Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitisGiorgia Colombo, Nausicaa Clemente, Andrea Zito, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2020
Circulating T-cell Immunosenescence in Patients with Advanced Non-small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based ChemotherapyRoberto Ferrara, Marie Naigeon, Edouard Auclin, et al.Cell Reports|February 16, 2024
ZEB1 shapes AML immunological niches, suppressing CD8 T cell activity while fostering Th17 cell expansionBarbara Bassani, Giorgia Simonetti, Valeria Cancila, et al.Clinical Lung Cancer|August 10, 2022
Circulating Fatty Acid Profile as a Biomarker for Immunotherapy in Advanced Non-Small Cell Lung CancerGiulia Galli, Paola Antonia Corsetto, Claudia Proto, et al.Journal of Experimental & Clinical Cancer Research : CR|May 14, 2026
Circulating extracellular vesicles from early-stage lung cancer patients trigger endothelial activation to drive pre-metastatic niche formation through synergistic miR-29a and C4A signalingFrancesca Pontis, Patrizia Ghidotti, Nicole Ferrario, et al.Cancer Research|April 9, 2020
Tumor-Derived Prostaglandin E2 Promotes p50 NF-κB-Dependent Differentiation of Monocytic MDSCsChiara Porta, Francesca Maria Consonni, Sara Morlacchi, et al.Lung Cancer (Amsterdam, Netherlands)|November 2, 2023
High bone tumor burden to identify advanced non-small cell lung cancer patients with survival benefit upon bone targeted agents and immune checkpoint inhibitorsSara Manglaviti, Marta Bini, Giulia Apollonio, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2018
Antibody-Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non-small Cell Lung Cancer Subsequent to PD-1/PD-L1 BlockadeGiuseppe Lo Russo, Massimo Moro, Michele Sommariva, et al.Clinical Lung Cancer|March 23, 2023
The EU-funded I3LUNG Project: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With ImmunotherapyArsela Prelaj, Monica Ganzinelli, Francesco Trovo', et al.Science Translational Medicine|February 16, 2018
Microenvironmental regulation of the IL-23R/IL-23 axis overrides chronic lymphocytic leukemia indolenceGiovanna Cutrona, Claudio Tripodo, Serena Matis, et al.Pageof 9